1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for CLDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 1991. Start Trial.
Date Value
September 24, 2026 22.97%
September 23, 2026 28.44%
September 22, 2026 34.79%
September 21, 2026 53.96%
September 18, 2026 47.53%
September 17, 2026 59.36%
September 16, 2026 57.49%
September 15, 2026 57.18%
September 14, 2026 60.25%
September 11, 2026 46.43%
September 10, 2026 52.64%
September 09, 2026 59.59%
September 08, 2026 67.18%
September 04, 2026 74.19%
September 03, 2026 66.75%
September 02, 2026 78.97%
September 01, 2026 77.72%
August 31, 2026 79.48%
August 28, 2026 74.80%
August 27, 2026 79.03%
August 26, 2026 86.53%
August 25, 2026 87.96%
August 24, 2026 80.63%
August 21, 2026 83.38%
August 20, 2026 91.19%
Date Value
August 19, 2026 73.61%
August 18, 2026 70.71%
August 17, 2026 64.39%
August 14, 2026 68.20%
August 13, 2026 70.51%
August 12, 2026 88.53%
August 11, 2026 121.5%
August 10, 2026 108.0%
August 07, 2026 96.65%
August 06, 2026 93.84%
August 05, 2026 85.54%
August 04, 2026 79.13%
August 03, 2026 69.85%
July 31, 2026 73.16%
July 30, 2026 68.72%
July 29, 2026 70.89%
July 28, 2026 61.65%
July 27, 2026 52.68%
July 24, 2026 51.94%
July 23, 2026 48.39%
July 22, 2026 55.50%
July 21, 2026 61.65%
July 20, 2026 58.05%
July 17, 2026 53.90%
July 16, 2026 54.05%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Gilead Sciences, Inc. 34.94%
ACADIA Pharmaceuticals, Inc. 4.33%
Alnylam Pharmaceuticals, Inc. -45.55%
Anika Therapeutics, Inc. 123.0%
Savara, Inc. 44.44%